BioMaP-Consortium RPP-24-03-Sterilization supports a strategic goal of ASPR, BARDA, and the Defense Production Act (DPA) Title III program, which seeks to expand domestic sterilization capacity to enable U.S. suppliers to support the production of 600 million vaccine doses within six to nine months with minimal disruption to the baseline public health supply chain.  This requirement is becoming increasingly acute due to the reliance on unstable global sources of supply for Cobalt 60, and an increasing reliance on alternative and emerging technologies such as X-ray or dual Electron Beam (E-Beam)/X-ray sterilization capabilities.

Member Organization: Meissner Filtration Products, Inc.

Award Date: 08/22/2024

Award Ceiling: $11,678,000

Project Duration: 26 months

Solicitation Number: RPP-24-03-Sterilization

Project Objective: Meissner will operationalize an X-ray irradiation facility that appreciably augments domestically available sterilization capacity in aggregate and this capacity  will be available industry wide as a CMO service, and be maintained in manner which ensures availability of surge capacity during periods of peak demand such as PHE.

Member Organization: Sterigenics Radiation Technologies LLC

Award Date: 03/07/2025

Award Ceiling: $9,243,129

Project Duration: 10 months

Solicitation Number: RPP-24-03-Sterilization

Project Objective: The purpose of the project is to expand X-ray capacity in North America. The addition of a greenfield X-ray irradiator will expand photon capacity and complement our existing gamma network located in the Southeast region of the US.

Member Organization: Steri-Tek LLC

Award Date: 03/26/2025

Award Ceiling: $12,766,831

Project Duration: 39 months

Solicitation Number: RPP-24-03-Sterilization